Aetna Wun Trombley, Lycia CEO
August 25, 2021 10:56 AM EDTUpdated 03:32 PM
Deals

Eli Lil­ly keeps its foot on deal­mak­ing ped­al, re­cruit­ing Car­olyn Bertozzi's pro­tein degra­da­tion tech for $1.6B+

Max Gelman

Senior Editor

Eli Lil­ly is stay­ing busy dur­ing the sum­mer months, wheel­ing and deal­ing its way to new deals. On Wednes­day, the Big Phar­ma sealed its lat­est …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

Met­sera rais­es $215M for stud­ies of GLP-1 and amylin obe­si­ty drugs

Adap­ti­m­mune's sec­ond T cell re­cep­tor cell ther­a­py for rare sar­co­mas pass­es piv­otal test

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

J&J takes 340B fight with fed­er­al gov­ern­ment to court

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times